SEARCH RESULTS FOR: "Tag: BIIB"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(11)
2018(11)
2017(19)
2016(20)
2015(23)
2014(3)
CATEGORIES
5-Minute Market Rundown(3)
Analyst Downgrades(4)
Analyst Update(11)
Analyst Upgrades(5)
Buzz Stocks(21)
By the Numbers(4)
Earnings Preview(3)
Expectational Analysis(2)
Ezines(2)
General(14)
Intraday Option Activity(10)
Market Recap(1)
Midday Market Check(5)
Opening View(5)
Quantitative Analysis(2)
Stock Market News(4)
Stocks On the Move(12)
Technical Analysis(1)

7/5/2019 3:06 PM
It was a solid week for stocks, with the Fourth of July holiday offering an abbreviated start to the new month. The Dow, S&P 500, and Nasdaq used early-week trade truce momentum to nab weekly wins,...
7/1/2019 10:23 AM
The shares of Biogen Inc (NASDAQ:BIIB) are up 0.9% at $236 after the firm said its spinal muscular atrophy treatment Spinraza was well tolerated in patients with the disease, with many seeing "unprec...
7/1/2019 9:21 AM
A warm reception to this weekend's trade talks between U.S. President Donald Trump and China's President Xi Jinping on the sidelines of the G-20 meeting has Dow futures surging more than 200 points ...
6/28/2019 10:55 AM
Biogen Inc (NASDAQ:BIIB) stock is trading down 1.8% at $235.42, after Piper Jaffray downgraded the biotech to "neutral" from "overweight," and lowered its price target to $250 from $280. The brokerage...
5/24/2019 10:55 AM
Biogen Inc (NASDAQ:BIIB) stock suffered its worst day in 14 years on March 21, when it gapped 29.2% lower on a pair of halted Alzheimer's disease drug trials. The shares have since struggled to surpas...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center